GENENTECH, INC for GENENTECH INC
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 budget Resolution Comparative Effectiveness H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT New | — |
| WALTER MOORE | — |
| PETER JOSEPH MULLER | — |
| HEIDI L WAGNER | — |
Health Issues HCR
H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 S. 3101 Improvements for Patients and Providers Act of 2008 H.R. 5629 Pathway for Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT New | — |
| WALTER MOORE | — |
| PETER JOSEPH MULLER | — |
| HEIDI L WAGNER | — |
Taxation/Internal Revenue Code TAX
Tax legislation/R&D tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT New | — |
| WALTER MOORE | — |
| PETER JOSEPH MULLER | — |
| HEIDI L WAGNER | — |
Copyright/Patent/Trademark CPT
S. 1145, Patent Reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008 HR 5629 - Pathways to Biosimilars Act S.623 - Access to Life-Saving Medicine Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT New | — |
| WALTER MOORE | — |
| PETER JOSEPH MULLER | — |
| HEIDI L WAGNER | — |
Medicare/Medicaid MMM
H.R. 5480, Medicare Funding Warning Response Act of 2008 H.R. 1424, Emergency Economic Stabilization Act of 2008 S. 2029, Physician Payments sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008Comparative Effectiveness Comparative Effectiveness H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT New | — |
| WALTER MOORE | — |
| PETER JOSEPH MULLER | — |
| HEIDI L WAGNER | — |
Pharmacy PHA
H.R. 1038, Acces to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H.R. 5629, Pathway for Biosimilars Act H.R. 4911, Human Growth Hormone Restriction Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 1505 Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT New | — |
| WALTER MOORE | — |
| PETER JOSEPH MULLER | — |
| HEIDI L WAGNER | — |
Medical/Disease Research/Clinical Labs MED
LHHS Appropriations (CMS and comparative effectiveness related matters)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT New | — |
| WALTER MOORE | — |
| PETER JOSEPH MULLER | — |
| HEIDI L WAGNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.